Everence Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Everence Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21,670	Closed	-$1.14M	–	755
2020 Q3	$1.14M	Hold	21,670	–	–	0.13%	138
2020 Q2	$682K	Hold	21,670	–	–	0.08%	201
2020 Q1	$589K	Buy	21,670 +6,930	+47%	+$193K	0.08%	201
2019 Q4	$291K	Hold	14,740	–	–	0.04%	487
2019 Q3	$191K	Hold	14,740	–	–	0.03%	583
2019 Q2	$184K	Hold	14,740	–	–	0.03%	587
2019 Q1	$214K	Buy	+14,740	New	+$188K	0.04%	527

Everence Capital Management's MNTA Position: Q4 2020 in Review

Everence Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 21,670 shares — an estimated $1.14M sold.

Everence Capital Management first reported a position in MNTA in Q1 2019 and held it in 7 quarters. The position peaked at $1.14M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Everence Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Everence Capital Management sold 21,670 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.14M.
Everence Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 7 quarters.
Everence Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.14M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Everence Capital Management's 13F filing for Q4 2020, filed 11 Jan 2021.